Differential Modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of Host Peripheral Lipid Metabolism and Histone Acetylation in Mouse Gut Organoids

Autor: Sabina Lukovac, Clara Belzer, Linette Pellis, Bart J. Keijser, Willem M. de Vos, Roy C. Montijn, Guus Roeselers

Publikováno v: mBio, Vol 5, Iss 4 (2014)

ABSTRACT The gut microbiota is essential for numerous aspects of human health. However, the underlying mechanisms of many host-microbiota interactions remain unclear. The aim of this study was to characterize effects of the microbiota on host epithel

Externí odkaz: https://doaj.org/article/f0fac67d694c44dda4c1534155d2c36c

Introduction of Heated Cow’s Milk Protein in Challenge-Proven Cow’s Milk Allergic Children

Autor: Nicolette W. de Jong, Marloes E. van Splunter, Joyce A. M. Emons, Kasper A. Hettinga, Roy Gerth van Wijk, Harry J. Wichers, Huub F. J. Savelkoul, Aline B. Sprikkelman, R. J. Joost van Neerven, Liu Liu, Gerbrich van der Meulen, Irene Herpertz, Yvonne C. M. Duijvestijn, Mijke Breukels, Marianne I. Brouwer, Jaap Schilperoord, Olga van Doorn, Berber Vlieg-Boerstra, Jochum van den Berg, Linette Pellis, Severina Terlouw, Astrid I. Hendriks, Marco W. J. Schreurs, Frank E. van Boven, Nicolette J. T. Arends

Publikováno v: Nutrients, 14(3):629. Multidisciplinary Digital Publishing Institute (MDPI)
Nutrients, 14(3):629. MDPI AG
Nutrients, 14(3)
Nutrients 14 (2022) 3
Nutrients, Vol 14, Iss 629, p 629 (2022)

The introduction of baked milk products in cow’s milk (CM) allergic children has previously been shown to accelerate induction tolerance in a selected group of children. However, there is no standardized baked milk product on the market. Recently,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::210ec14cf351e553ea578fdc6ebbb576
https://pure.eur.nl/en/publications/0b87ab16-654d-4c6a-84c7-189ba45ae48f

Accelerating Tolerance Induction In Cow's Milk Allergic Children By Heated Cow's Milk Protein: The iAGE Follow-up Study

Autor: Nicolette De Jong, Nicolette Arends, Aline Sprikkelman, Joyce Emons, Astrid Hendriks, Marloes van Splunter, Marco Schreurs, Severina Terlouw, LInette Pellis, Roy Gerth van Wijk, Harry Wichers, Huub Savelkoul, Joost van Neerven, Kasper Hettinga, Frank van Boven

Publikováno v: Journal of Allergy and Clinical Immunology. 151:AB179

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c947be4655fa76089b52d7822c6cd6ba
https://doi.org/10.1016/j.jaci.2022.12.559

Multi-parameter comparison of a standardized mixed meal tolerance test in healthy and type 2 diabetic subjects: the PhenFlex challenge

Autor: Annette Stafleu, G.C.M. Bakker, Jacobus Burggraaf, Ben van Ommen, Linette Pellis, Alwine A. F. Kardinaal, Marjan van Erk, Ruud Boessen, Johanna H. M. Stroeve, Suzan Wopereis

Publikováno v: Genes & Nutrition, Vol 12, Iss 1, Pp 1-14 (2017)
Genes & nutrition, 12:21
Genes & Nutrition
Genes & Nutrition, 21, 12

Background A key feature of metabolic health is the ability to adapt upon dietary perturbations. Recently, it was shown that metabolic challenge tests in combination with the new generation biomarkers allow the simultaneous quantification of major me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35bc4f9f28f526e56c0c35c0117045dc
http://link.springer.com/article/10.1186/s12263-017-0570-6

Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes

Autor: Ilse K. Geerars-van Vonderen, Ben van Ommen, Linette Pellis, Henk den Ouden, Guy E.H.M. Rutten, Marjan van Erk, Joline W.J. Beulens, Carina M. Rubingh

Publikováno v: den Ouden, H, Pellis, L, Rutten, G E H M, Geerars-van Vonderen, I K, Rubingh, C M, van Ommen, B, van Erk, M J & Beulens, J W J 2016, ' Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes ', Metabolomics, vol. 12, no. 2, 27, pp. 1-9 . https://doi.org/10.1007/s11306-015-0930-4
Metabolomics
Metabolomics, 12(2):27, 1-9
Metabolomics, 12(2). Springer New York

We aimed to identify metabolites to predict patients’ response to glucose lowering treatment during the first 5 years after detection of type 2 diabetes. Metabolites were measured by GC–MS in baseline samples from 346 screen-detected type 2 diabe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94dc2de499b738e2be3d24fdac3caeaf
https://research.vumc.nl/en/publications/461daab3-a258-4372-ae63-e232c0a0b1a8